RAJIV B NANAVATY
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology SUFFOLK, VA NPI 1013937564
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology VA ABBVIE INC. All categories
General Payments — all program years on this page
$7,854.82
- Category: General Payments
- Program years: PY2018–2024
- Record count: 338
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,731.25 across 71 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,731.25 | 71 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $349.89 | 13 |
| Biogen, Inc. | $284.05 | 16 |
| SK Life Science, Inc. | $173.61 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $154.33 | 14 |
| EISAI INC. | $147.06 | 2 |
| Genentech USA, Inc. | $115.15 | 4 |
| Kowa Pharmaceuticals America, Inc. | $100.63 | 1 |
| BANNER LIFE SCIENCES, LLC | $51.14 | 2 |
| Alexion Pharmaceuticals, Inc. | $45.08 | 2 |
| EMD Serono, Inc. | $44.64 | 1 |
| Neurelis, Inc. | $36.69 | 2 |
| Lundbeck LLC | $34.29 | 1 |
| Teva Pharmaceuticals USA, Inc. | $32.69 | 2 |
| Sumitomo Pharma America, Inc. | $27.68 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $21.74 | 1 |
| UCB, Inc. | $21.66 | 1 |
| PFIZER INC. | $20.35 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.54 | 1 |
| Celgene Corporation | $18.10 | 1 |
| Lilly USA, LLC | $16.50 | 1 |
| Amneal Pharmaceuticals LLC | $16.43 | 1 |
By program year
Records — PY2024 (71)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.